We urge you to utilize analysis of DarioHealth Corp fundamentals to see if markets are presently mispricing the company. We found thirty-four available fundamental indicators for DarioHealth Corp which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all DarioHealth Corp fundamentals including its Price to Sales, Cash Flow from Operations, Current Liabilities, as well as the relationship between Cash and Equivalents and Market Capitalization . Please also check DarioHealth Corp Number of Shares Shorted to verify the company can sustain itself down the road.Use DarioHealth Corp to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of DarioHealth Corp to be traded at $1.4016 in 30 days
DarioHealth Corp Company SummaryDarioHealth Corp competes with Edwards Lifesciences, Digirad, and . Its flagship product is Dario Smart Diabetes Management Solution a mobile realtime cloudbased diabetes management solution based on a multifeature software application combined with Dario Smart Meter a pocketsized blood glucose monitoring device. LabStyle Innovations Corp is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement as well as various general methods of rapid tests of body fluids using mobile devices and cloudbased services. LabStyle Innovations Corporation was founded in 2011 and is headquartered in Caesarea Israel.
DarioHealth Corp Price to Book vs Beta
DarioHealth Corp is rated # 2 in price to book category among related companies. It is rated # 3 in beta category among related companies .